Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment

Clinical trial NCT06671444 · COMPLETED

Trial details

NCT number: NCT06671444
Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Insomnia Renal Impairment

Start date: 2024-06-03
Primary completion: 2024-10-11
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.